Amy E.L. Stone

620 citations
15 papers · 412 indexed · h-index 8
Topics
interferon and immune responses (8 papers)Hepatitis C virus research (6 papers)Influenza Virus Research Studies (4 papers)

In The Last Decade

Amy E.L. Stone

15 papers receiving 406 citations

Peers

Amy E.L. Stone
Comparison fields: 5 of 45
  • Immunology 222
  • Hepatology 145
  • Epidemiology 133
  • Molecular Biology 114
  • Infectious Diseases 66
Replace Hideko Nuriya with:
Hideko Nuriya Japan
Erwin Daniel Brenndörfer Sweden
Mayumi Ueyama Japan
Arjan Boltjes Netherlands
Huifan Ji China
Chaoyang Wen China
Kim Kreefft Netherlands
Michelle Chung United States
Libo Tang China
Hiroyoshi Doi Japan
Amy E.L. Stone relative to Hideko Nuriya Japan Hideko Nuriya's profile →
Citations per field
00.5×3.6×
Hideko Nuriya · 1×
Citations per year

Countries citing papers authored by Amy E.L. Stone

Since Specialization
Citations

This map shows the geographic impact of Amy E.L. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E.L. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E.L. Stone more than expected).

Fields of papers citing papers by Amy E.L. Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E.L. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E.L. Stone. The network helps show where Amy E.L. Stone may publish in the future.

Co-authorship network of co-authors of Amy E.L. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E.L. Stone. A scholar is included among the top collaborators of Amy E.L. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E.L. Stone. Amy E.L. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 3
2 1
3 1
4 50
5 97
6 26
7 1
8 1
9 12
10
The 13th Annual Meeting of the Rocky Mountain Virology Association: Current Advances in Virology and Prion Biology in the Rocky Mountain region
1
11 25
12 96
13 4
14 52
15 42

About Amy E.L. Stone

Amy E.L. Stone is a scholar working on Hepatology, Immunology and Epidemiology, having authored 15 papers that have together received 412 indexed citations. Recurring topics across this work include interferon and immune responses (8 papers), Hepatitis C virus research (6 papers) and Influenza Virus Research Studies (4 papers). The work is most often cited by research in Hepatology (145 citations), Immunology (222 citations) and Epidemiology (133 citations). Amy E.L. Stone has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Michael Gale, Hugo R. Rosen, Lucy Golden‐Mason, Linling Cheng, Silvia Giugliano, Courtney Wilkins, Richard Green, Emily A. Hemann, Angela M. Mitchell and Kiran Bambha. Their work appears in journals such as Nature Communications, Nature Immunology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026